Akèy › Kolit Ulseratif › Washington › Tacoma
Etid klinik pou Kolit Ulseratif nan Tacoma, WA
15 etid pou Kolit Ulseratif ap chèche patisipan nan sit nan ak bò kote Tacoma (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
Ap rekriteFaz 2
- Washington Gastroenterology - Tacoma /ID# 284143, Tacoma
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
Ap rekriteFaz 2
- Site 019, Tacoma
A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
Ap rekriteFaz 2
- Site US-029, Tacoma
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
Ap rekriteFaz 3
- GI Alliance Tacoma, Tacoma
A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
Ap rekriteFaz 2/3
- MultiCare Health System, Tacoma
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
Ap rekriteFaz 3
- Washington Gastroenterology - Tacoma, Tacoma
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Ap rekriteFaz 2
- Washington Gastroenterology - Tacoma, Tacoma
A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
Ap rekriteFaz 4
- Washington Gastroenterology- GIA, Tacoma
Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
Ap rekriteFaz 3
- Washington Gastroenterology - Tacoma ( Site 0295), Tacoma
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
Ap rekriteFaz 3
- GI Alliance Tacoma, Tacoma
A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis
Ap rekriteFaz 2
- Digestive Health Specialists, Tacoma
A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease
Ap rekriteFaz 3
- MultiCare Institute for Research & Innovation, Tacoma
An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
Ap rekriteEtid obsèvasyon
- Washington Gastroenterology, Tacoma
A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
Ap rekriteFaz 3
- Multicare Health System Institute for Research and Innovation, Tacoma
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
Ap rekriteFaz 2
- Mirador Therapeutics Selected Site, Tacoma
Etid Kolit Ulseratif nan lòt vil
- New York City, NY24 etid
- Orlando, FL23 etid
- Miami, FL22 etid
- Houston, TX18 etid
- San Antonio, TX16 etid
- Chicago, IL15 etid
- San Diego, CA15 etid
- Colorado Springs, CO14 etid
- St. Louis, MO14 etid
- Tyler, TX14 etid
- Los Angeles, CA13 etid
- Boston, MA12 etid
Lòt etid nan Tacoma
- Kansè Poumon ki pa ti selil20 etid
- Kansè nan tete18 etid
- Myelom Miltip13 etid
- Kansè pwostat11 etid
- Maladi Crohn11 etid
- Kansè Metastatik9 etid
- Kansè kolorektal9 etid
- Melanom7 etid
- Kansè ovè7 etid
- Obèsite6 etid
- Kansè (tout kalite)6 etid
- Kansè pankreyas6 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.